| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.003 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.003 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.095 | 0.003 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.003 |